Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
Mitochondria mutations that may combat cancer
Fri April 9th - Mitochondrial DNA mutations found in cancer tumours are linked to improved chances of survival, researchers have found. More
Sun but not vitamin D may reduce COVID risk
Fri April 9th - Exposure to sun may have helped reduce mortality from COVID-19 – but vitamin D is probably not the explanation, according to a new UK study published today. More
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote: on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...

Concerns over racial disparities in dementia treatment

Monday January 20th, 2020

Black and Asian people with dementia in the UK do not receive the same quality of care as white patients with the same condition, a new study claims today.

The research, led by UCL, found that Asian people with dementia are less likely to receive anti-dementia drugs, and will take them for shorter periods, while those from black ethnic groups tend to be prescribed antipsychotic drugs and take them for about four weeks longer per year compared to white people.

Professor Claudia Cooper, of UCL’s Psychiatry department, described the findings, published in the latest edition of Clinical Epidemiology, as “concerning”.

The research team used data from The Health Improvement Network primary care database between 2014 and 2016, analysing 53,718 people with dementia and 1,648,889 people without the condition.

They found that Asian dementia patients were 14% less likely than their white counterparts to be prescribed anti-dementia drugs when they were potentially beneficial - and received them for an average of 15 fewer days per year.

Both black and Asian people with dementia were also found to be prescribed antipsychotic drugs for longer than white patients – 27 and 17 days more, respectively – which puts them at greater risk of suffering harmful side effects.

The data backs up studies carried out in the USA and Australia. These also found disparities in drug treatment for dementia for minority ethnic groups.

The researchers say disparities in prescribing could partly ascribed to greater socioeconomic disadvantages experienced by minority ethnic groups, which lead to barriers to accessing care, as well as language and cultural barriers.

Professor Cooper said: “Our new findings are concerning as they appear to reflect inequalities in the care people receive to treat symptoms associated with dementia.

“Rates of antipsychotic prescribing in all ethnic groups exceeded recommendations for treating the often very distressing behavioural and psychological symptoms of dementia, such as agitation or challenging behaviours, which are the most common reasons antipsychotic drugs are prescribed to people living with dementia.

“While there has been a very sharp reduction in antipsychotic prescribing in the UK over the past ten years, these figures suggest there is still work to do to ensure that people with dementia only receive potentially harmful antipsychotic drugs if there are no acceptable alternatives.”

Jones ME, Petersen I, Walters K et al. Differences in psychotropic drug prescribing between ethnic groups of people with dementia in the United Kingdom. Clinical Epidemiology 20 January 2020.

Tags: Brain & Neurology | Elderly Health | Mental Health | Pharmaceuticals | UK News

Printer friendly page Printer friendly page

Comment on this article:

<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)